Nublexa 40mg Tablet

About

Nublexa 40mg Tablet is a targeted therapy medication employed in the treatment of specific types of cancer. It functions as a tyrosine kinase inhibitor (TKI), a class of drugs that selectively block the activity of certain enzymes crucial for cancer cell growth, proliferation, and survival. By inhibiting these aberrant signaling pathways, Nublexa effectively helps to slow down or halt the progression of the disease, offering a more precise approach to cancer treatment compared to traditional chemotherapy. This precision medicine strategy aims to minimize damage to healthy cells while specifically targeting cancerous ones that rely on these pathways for their uncontrolled growth. It is typically prescribed following a comprehensive diagnostic evaluation to confirm the presence of specific molecular markers, ensuring its potential efficacy for the individual patient. Regular monitoring is essential to assess response and manage any potential side effects.

Uses

• Treatment of specific solid tumors.
• Management of certain hematological malignancies.
• Inhibition of tumor growth and metastasis.
• Targeted therapy for resistant cancers.

Directions For Use

Take orally once daily with or without food, as directed by your oncologist. Do not crush, chew, or split the tablet.

Benefits

• Targets specific cancer pathways.
• Slows tumor growth and progression.
• May improve progression-free survival.
• Offers a personalized treatment approach.
• Potentially reduces tumor size.
• Can be effective in resistant cases.

Side Effects

• Fatigue.
• Nausea.
• Diarrhea.
• Skin rash.
• Hypertension (high blood pressure).
• Hand-foot syndrome.
• Liver enzyme elevation.
• Proteinuria (protein in urine).
• Headache.
• Abdominal pain.
• Anemia.
• Thrombocytopenia (low platelet count).

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may exacerbate liver side effects and increase toxicity.
• Pregnancy - Contraindicated; can cause fetal harm. Use effective contraception during treatment and for a period after.
• Breastfeeding - Not recommended; discontinue breastfeeding during treatment and for a period after the last dose.
• Liver - Use with caution in patients with liver impairment; monitor liver function closely and adjust dosage as needed.
• Kidney - Use with caution in patients with kidney impairment; dosage adjustment may be necessary based on renal function.
• Lung - Monitor for interstitial lung disease (ILD) or pneumonitis; report new or worsening respiratory symptoms immediately.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.